These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
113 related articles for article (PubMed ID: 12223258)
41. Lateral ventricle differences between first-episode schizophrenia and first-episode psychotic bipolar disorder: A population-based morphometric MRI study. Rosa PG; Schaufelberger MS; Uchida RR; Duran FL; Lappin JM; Menezes PR; Scazufca M; McGuire PK; Murray RM; Busatto GF World J Biol Psychiatry; 2010 Oct; 11(7):873-87. PubMed ID: 20545464 [TBL] [Abstract][Full Text] [Related]
42. Neural stem cell proliferation is decreased in schizophrenia, but not in depression. Reif A; Fritzen S; Finger M; Strobel A; Lauer M; Schmitt A; Lesch KP Mol Psychiatry; 2006 May; 11(5):514-22. PubMed ID: 16415915 [TBL] [Abstract][Full Text] [Related]
43. Hippocampal α7 nicotinic acetylcholine receptor levels in patients with schizophrenia, bipolar disorder, or major depressive disorder. Thomsen MS; Weyn A; Mikkelsen JD Bipolar Disord; 2011; 13(7-8):701-7. PubMed ID: 22085484 [TBL] [Abstract][Full Text] [Related]
44. Differences in neuroanatomical sites of apoD elevation discriminate between schizophrenia and bipolar disorder. Thomas EA; Dean B; Scarr E; Copolov D; Sutcliffe JG Mol Psychiatry; 2003 Feb; 8(2):167-75. PubMed ID: 12610649 [TBL] [Abstract][Full Text] [Related]
45. Oligodendroglial density in the prefrontal cortex in schizophrenia and mood disorders: a study from the Stanley Neuropathology Consortium. Uranova NA; Vostrikov VM; Orlovskaya DD; Rachmanova VI Schizophr Res; 2004 Apr; 67(2-3):269-75. PubMed ID: 14984887 [TBL] [Abstract][Full Text] [Related]
46. Evaluation of superior vermal Purkinje cell placement in mental illness. Helmkamp CE; Bigelow LB; Paltán-Ortiz JD; Torrey EF; Kleinman JE; Herman MM Biol Psychiatry; 1999 May; 45(10):1370-5. PubMed ID: 10349043 [TBL] [Abstract][Full Text] [Related]
47. Altered levels of the synaptosomal associated protein SNAP-25 in hippocampus of subjects with mood disorders and schizophrenia. Fatemi SH; Earle JA; Stary JM; Lee S; Sedgewick J Neuroreport; 2001 Oct; 12(15):3257-62. PubMed ID: 11711867 [TBL] [Abstract][Full Text] [Related]
48. Upregulation of the initiating step of the kynurenine pathway in postmortem anterior cingulate cortex from individuals with schizophrenia and bipolar disorder. Miller CL; Llenos IC; Dulay JR; Weis S Brain Res; 2006 Feb; 1073-1074():25-37. PubMed ID: 16448631 [TBL] [Abstract][Full Text] [Related]
50. A histological study of the corpus callosum in chronic schizophrenia. Nasrallah HA; McCalley-Whitters M; Bigelow LB; Rauscher FP Psychiatry Res; 1983 Apr; 8(4):251-60. PubMed ID: 6576392 [TBL] [Abstract][Full Text] [Related]
51. Expression of cellular prion protein (PrP(c)) in schizophrenia, bipolar disorder, and depression. Weis S; Haybaeck J; Dulay JR; Llenos IC J Neural Transm (Vienna); 2008 May; 115(5):761-71. PubMed ID: 18188498 [TBL] [Abstract][Full Text] [Related]
52. Amygdala volume and verbal memory performance in schizophrenia and bipolar disorder. Killgore WD; Rosso IM; Gruber SA; Yurgelun-Todd DA Cogn Behav Neurol; 2009 Mar; 22(1):28-37. PubMed ID: 19372768 [TBL] [Abstract][Full Text] [Related]
53. Temporal lobe structure as determined by nuclear magnetic resonance in schizophrenia and bipolar affective disorder. Johnstone EC; Owens DG; Crow TJ; Frith CD; Alexandropolis K; Bydder G; Colter N J Neurol Neurosurg Psychiatry; 1989 Jun; 52(6):736-41. PubMed ID: 2746266 [TBL] [Abstract][Full Text] [Related]
54. Voxel-based morphometry of patients with schizophrenia or bipolar disorder and their unaffected relatives. McIntosh AM; Job DE; Moorhead TW; Harrison LK; Forrester K; Lawrie SM; Johnstone EC Biol Psychiatry; 2004 Oct; 56(8):544-52. PubMed ID: 15476683 [TBL] [Abstract][Full Text] [Related]
55. A study of hippocampal shape anomaly in schizophrenia and in families multiply affected by schizophrenia or bipolar disorder. Connor SE; Ng V; McDonald C; Schulze K; Morgan K; Dazzan P; Murray RM Neuroradiology; 2004 Jul; 46(7):523-34. PubMed ID: 15205862 [TBL] [Abstract][Full Text] [Related]
56. Altered myelination of the hippocampal formation in subjects with schizophrenia and bipolar disorder. Chambers JS; Perrone-Bizzozero NI Neurochem Res; 2004 Dec; 29(12):2293-302. PubMed ID: 15672553 [TBL] [Abstract][Full Text] [Related]
57. Glial fibrillary acidic protein mRNA levels in the cingulate cortex of individuals with depression, bipolar disorder and schizophrenia. Webster MJ; O'Grady J; Kleinman JE; Weickert CS Neuroscience; 2005; 133(2):453-61. PubMed ID: 15885920 [TBL] [Abstract][Full Text] [Related]
59. Cortical bcl-2 protein expression and apoptotic regulation in schizophrenia. Jarskog LF; Gilmore JH; Selinger ES; Lieberman JA Biol Psychiatry; 2000 Oct; 48(7):641-50. PubMed ID: 11032975 [TBL] [Abstract][Full Text] [Related]
60. A change in the density of [(3)H]flumazenil, but not [(3)H]muscimol binding, in Brodmann's Area 9 from subjects with bipolar disorder. Dean B; Pavey G; McLeod M; Opeskin K; Keks N; Copolov D J Affect Disord; 2001 Oct; 66(2-3):147-58. PubMed ID: 11578667 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]